Skip to main content
Log in

Ferumoxtran-10

AMI 227, AMI 227cn, AMI 27, BMS 180549, Combidex®, G 53425, Sinerem™

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II

Notes

  1. This profile has been selected from R&D Insight™, a pharmaceutical intelligence database produced by Adis International Ltd.

References

  1. Advanced Magnetics Inc. Advanced Magnetics, Inc. Reports Fourth Fiscal Quarter And Year End Results. Media Release: 22 Nov 2002. Available from URL: http://www.advancedmagnetics.com

    Google Scholar 

  2. Advanced Magnetics Inc, Cytogen Corporation. National Cancer Institute to Study use of Advanced Magnetics’ MRI Contrast Agents, Combidex(R) and Code 7228, in Detection of Metastatic Lymph Node Disease. Media Release: 30 Sep 2002. Available from URL: http://www.advancedmagnetics.com

    Google Scholar 

  3. Mclachlan SJ, Morris MR, Lucas MA, et al. Phase-I clinical evaluation of a new iron oxide MR contrast agent. JMRI — Journal of Magnetic Resonance Imaging 4: 301–307, May–Jun 1994

    Article  CAS  Google Scholar 

  4. Small WC, Nelson RC, Bernardino ME. Dual contrast enhancement of both T-1- and T-2-weighted sequences using ultrasmall superparamagnetic iron oxide. Magnetic Resonance Imaging 11: 645–654, No. 5, 1993

    Article  PubMed  CAS  Google Scholar 

  5. Harisinghani MG, Saini S, Weissleder R, Rubin D, deLange E, et al. Splenic imaging with ultrasmall superparamagnetic iron oxide Ferumoxtran-10 (AMI-7227): preliminary observations. Journal of Computer Assisted Tomography 25: 770–776, Sep–Oct 2001

    Article  PubMed  CAS  Google Scholar 

  6. Varallyay P, Nesbit G, Muldoon LL, Nixon RR, Delashaw J, et al. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. American Journal of Neuroradiology 23: 510–519, Apr 2002

    PubMed  Google Scholar 

  7. Harisinghani M, Barentsz J, Han P, Deserno W, Marten K, et al. MR lymphangiography for detection of minimal nodal disease in patients with prostate cancer. 87th Scientific Assembly and Annual Meeting of the Radiological Society of North America: [2 pages], 25 Nov 2001. Available from URL: http://shows.rsna.org

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferumoxtran-10. Drugs in R&D 4, 52–54 (2003). https://doi.org/10.2165/00126839-200304010-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200304010-00009

Keywords

Navigation